The global cancer cachexia market is anticipated to gain traction from the rising shift of the healthcare providers towards combination therapies. Such therapies are aiding in improving the lean body mass (LBM) of patients. This information is given by Fortune Business Insights™ in a recently published report, titled, “Cancer Cachexia Market Size, Share & Covid-19 Impact Analysis, By Product (Progestogens, Corticosteroids, Combination Therapies, and Others), By Distributional Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The report further states that this market size was USD 2.02 billion in 2019 and is projected to reach USD 2.93 billion by 2027, thereby exhibiting a CAGR of 4.8% during the forecast period.
To get to know more about the short-term and long-term impacts of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/cancer-cachexia-market-103262
Detailed Table of Content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptionss
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of Cancer Cachexia, for Key Regions/ Country, 2019
4.2. Pipeline Analysis, By Key Players
4.3. Overview of Economic Cost Burden of Cancer & Supportive Care, for Key Regions/ Country
4.4 Key industry Developments – Mergers, Acquisition, Etc.
5. Global Cancer Cachexia Market Analysis, Insights and Forecast, 2016-2027
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Product
5.2.1 Progestogens
5.2.2 Corticosteroids
5.2.3 Combination Therapies
5.2.4 Others
5.3. Market Analysis, Insights and Forecast – By Distribution Channel
5.3.1 Hospital Pharmacy
5.3.2 Retail Pharmacy
5.3.3 Online Pharmacy
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1 North America
5.4.2 Europe
5.4.3 Asia pacific
5.4.4 Rest of World
6. North America Cancer Cachexia Market Analysis, Insights and Forecast, 2016-2027
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Product
6.2.1 Progestogens
6.2.2 Corticosteroids
6.2.3 Combination Therapies
6.2.4 Others
6.3. Market Analysis, Insights and Forecast – By Distribution Channel
6.3.1 Hospital Pharmacy
6.3.2 Retail Pharmacy
6.3.3 Online Pharmacy
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1 U.S.
6.4.2 Canada
7. Europe Cancer Cachexia Market Analysis, Insights and Forecast, 2016-2027
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Product
7.2.1 Progestogens
7.2.2 Corticosteroids
7.2.3 Combination Therapies
7.2.4 Others
7.3. Market Analysis, Insights and Forecast – By Distribution Channel
7.3.1 Hospital Pharmacy
7.3.2 Retail Pharmacy
7.3.3 Online Pharmacy
7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
7.4.1 U.K.
7.4.2 Germany
7.4.3 France
7.4.4 Spain
7.4.5 Italy
7.4.6 Scandinavia
7.4.7 Rest of Europe
Continued…
